Gatehouse Bio
Latest round
- Seed
Last raised
- Dec 2021
Total raised
- Undisclosed
Investors
- 2
About Gatehouse Bio
, formerly known as sRNAlytics, operates as an RNA therapeutic company. The company was founded by its CEO, David Salzman, and Neal Foster. Gatehouse develops various biotechnology solutions, mainly RNA therapeutics, a type of treatment that uses small RNAs (sRNAs) to target and treat a variety of diseases. The firm’s platform, Code-Breaker, utilizes artificial intelligence (AI) to find sRNAs and design biomarker-guided precision oligonucleotide therapeutics. The company develops therapies for pulmonary, cardiac, neurological, and autoimmune diseases.
Who invested in Gatehouse Bio
2 investors across 2 rounds
See all investors in Gatehouse Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Gatehouse Bio
Who invested in Gatehouse Bio?
Gatehouse Bio has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gatehouse Bio raised?
Gatehouse Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Gatehouse Bio last raise money?
Gatehouse Bio's most recent round on record is a Seed, in Dec 2021.
What does Gatehouse Bio do?
, formerly known as sRNAlytics, operates as an RNA therapeutic company.
Where is Gatehouse Bio headquartered?
Gatehouse Bio is headquartered in Natick, US.
Which VCs invest in companies like Gatehouse Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Gatehouse Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Gatehouse Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.